Assessment of cholinesterase and tyrosinase inhibitory and antioxidant effects of Hypericum perforatum L. (St. John's wort)

Industrial Crops and Products

Volumn 43, Issue 1, 2013, Pages 87-92

  Altun, M Levent ^a   Yilmaz, Betül Sever ^a   Orhan, Ilkay Erdogan ^b,c   Citoglu, Gülcin Saltan ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c EASTERN MEDITERRANEAN UNIVERSITY   (Turkey)

Author keywords

Antioxidant activity; Cholinesterase; Hypericaceae; Hypericum perforatum; St. John's wort; Tyrosinase

Indexed keywords

ANTIOXIDANT ACTIVITIES; CHOLINESTERASE; HYPERICACEAE; HYPERICUM PERFORATUM; ST. JOHN'S WORT; TYROSINASE;

METHANOL; NITRIC OXIDE; PHENOLS; PLANTS (BOTANY);

ESSENTIAL OILS;

ANTIOXIDANT; CHELATION; DICOTYLEDON; DISEASE CONTROL; ENZYME ACTIVITY; INHIBITION; INHIBITOR; METHANOL; NEUROLOGY; SCAVENGING (CHEMISTRY);

TURKEY;

CLUSIACEAE; HYPERICUM PERFORATUM;

EID: 84864446361     PISSN: 09266690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.indcrop.2012.07.017     Document Type: Article

References (35)

1. Asanuma M., Miyazaki I., Ogawa N. Dopamine- or l-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotoxicol. Res. 2003, 5:165-176.
2. Barnes J., Anderson L.A., Phillipson J.D. St. John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 2001, 53:583-600.
3. Benedi J., Arroyo R., Romero C., Martin-Aragon S., Villar A.M. Antioxidant properties and protective effects of a standardized extract of Hypericum perforatum on hydrogen peroxide-induced oxidative damage in PC12 cells. Life Sci. 2004, 75:1263-1276.
4. Blois M.S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181:1199-1200.
5. Calapai G., Crupi A., Firenzuoli F., Constantino G., Inferrera G., Campo G.M., Caputi A.P. Effects of Hypericum perforatum on the levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon, and brain stem of the rat. J. Pharm. Pharmacol. 1999, 51:723-728.
6. Chua M.T., Tung Y.T., Chang S.T. Antioxidant activities of ethanolic extracts from the twigs of Cinnamomum osmophleum. Biores. Technol. 2008, 99:1918-1925.
7. Davis P.H., Cullen J. Hypericaceae. Flora of Turkey and the East Aegean Islands 1984, vol. 10:96-103. Edinburgh University Press, Edinburgh.
8. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
9. El-Sherbiny D.A., Khalifa A.E., Attia A.S., Eldenshary Eel D. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol. Biochem. Behav. 2003, 76:525-533.
10. Falcioni G., Fedeli D., Tiano L., Calzuola I., Mancinelli L., Marsili V., Gianfranceschi G. Antioxidant activity of wheat sprouts extract in vitro: inhibition of DNA oxidative damage. J. Food Sci. 2002, 67:2918-2922.
11. Ferreira A., Proenca C., Serralheiro M.L., Araujo M.E. The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. J. Ethnopharmacol. 2006, 108:31-37.
12. Franchi G.G., Nencini C., Collavoli E., Massarelli P. Composition and antioxidant activity in vitro of different St. John's Wort (Hypericum perforatum L.) extracts. J. Med. Plants Res. 2011, 5:4349-4353.
13. Franklin M., Chi J., McGavin C., Hockney R., Reed A., Campling R.W., Cowen P.J. Neuroendocrine evidence for dopaminergic actions of Hypericum extract (LI 160) in healthy volunteers. Biol. Psychiatry 1999, 46:581-584.
14. Gioti E.M., Fiamegos Y.C., Skalkos D.C., Stalikas C.D. Antioxidant activity and bioactive components of the aerial parts of Hypericum perforatum L. from Epirus. Greece. Food Chem. 2009, 117:398-404.
15. Inestrosa N.C., Tapias-Rojas C., Griffith T.N., Carvajal F.J., Benito M.J., Rivera-Dictter A., Alvarez A.R., Serrano A.R., Hancke J.L., Burgos P.V., Parodi J., Varela-Nallar L. Tetrahydroperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing. Trans. Psychiatry 2011, 1:e20.
16. Ivanova D., Gerova D., Chervenkov T., Yankova T. Polyphenols and antioxidant capacity of Bulgarian medicinal plants. J. Ethnopharmacol. 2005, 96:145-150.
17. Khalifa A.E. Hypericum perforatum as nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice. J. Ethnopharmacol. 2001, 76:49-57.
18. Khan M.T.H., Orhan I., Senol F.S., Kartal M., şener B., Dvorska M., Smejkal K., Slapetova T. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. Chemicobiol. Interact. 2009, 181:383-389.
19. Klusa V., Germane S., Noldner M., Chattarjee S.S. Hypericum extract and hyperforin: memory-enhancing properties in rodents. Pharmacopsychology 2001, 34(Suppl. 1):S61-S69.
20. Marcocci I., Marguire J.J., Droy-Lefaiz M.T., Packer L. The nitric oxide scavenging properties of Ginkgo biloba extract. Biochem. Biophys. Res. Commun. 1994, 201:748-755.
21. Masuda T., Yamashita D., Takeda Y., Yonemori S. Screening for tyrosinase inhibitors among extracts of seashore plants and identification of potent inhibitors from Garcinia subelliptica. Biosci. Biotechnol. Biochem. 2005, 69:197-201.
22. Micheau J., Van Marrewijk B. Stimulation of 5-HT1A receptors by systemic or medial septum injection induces anxiogenic-like effects and facilitates acquisition of a spatial discrimination task in mice. Progr. Neuro-Psychopharmacol. Biol. Psychol. 1999, 23:1113-1133.
23. Newall C.A., Anderson L.A., Phillipson J.D. Herbal medicines. A Guide for Health-Care Professionals 1996, Pharmaceutical Press, London. 1st ed.
24. Nishimiki M., Rao N.A., Appaji N., Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun. 1972, 46:849-854.
25. Orcic D.Z., Mimika-Dukic N.M., Franciskovic M.M., Petrovic S.S., Jovin E.D. Antioxidant activity relationship of phenolic compounds in Hypericum perforatum L. Chem. Central J. 2011, 5:34-42.
26. Orhan G., Orhan I., Sener B. Recent developments in natural and synthetic drug research for Alzheimer's disease. Lett. Drug Design Disc. 2006, 3:268-274.
27. Oyaizu M. Studies on products of browning reactions-antioxidative activities of products of browning reaction prepared from glucosamine. Jap. J. Nutr. 1986, 44:307-315.
28. Ozturk N., Tuncel M., Potoglu-Erkara I. Phenolic compounds and antioxidant activities of some Hypericum species: a comparative study with H. perforatum. Pharm. Biol. 2009, 47:120-127.
29. Robson N.K.B. Hypericum botany. Hypericum: The Genus Hypericum 2003, 1-22. Taylor and Francis, New York. E. Ernst (Ed.).
30. Schlesier K., Harvat M., Bohm V., Bitsch R. Assessment of antioxidant activity by using different in vitro methods. Free Radic. Res. 2002, 36:177-187.
31. Senol S., Orhan I., Yilmaz G., çiçek M., Sener B. Acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibition studies and antioxidant activities of 33 Scutellaria L. taxa from Turkey. Food Chem. Toxicol. 2010, 48:781-788.
32. Singleton V.L., Rossi J.A. Colorimetry of total phenolics with phosphomolibdic-phosphotungtic acid reagents. Am. J. Enol. Viticult. 1965, 16:144-158.
33. Woisky R., Salatino A. Analysis of propolis: some parameters and procedures for chemical quality control. J. Apicol. Res. 1998, 37:99-105.
34. Wszelaki N., Kuciun A., Kiss A.K. Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity. Acta Pharm. 2010, 60:119-128.
35. Zhou Y., Lu Y., Wei D. Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in vitro. J. Agric. Food Chem. 2004, 52:5032-5039.